Paysign, Inc., a leading provider of financial technology solutions, has expanded its presence in the U.S. plasma market by being awarded 132 established plasma donation centers through its partnership with a major plasma collection company. This move will increase Paysign's market share to approximately 50% as it now supports over 615 plasma centers across 18 companies. The transition of these centers is expected to be completed by the third quarter of 2025. Paysign anticipates that the new centers will reach full revenue potential by early 2026 without a significant rise in operational expenses, demonstrating the company's operational efficiency and commitment to enhancing the donor experience.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.